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Until recently, basophils and mast cells were considered
mainly effector cells with an innate immune response linked
to allergy and parasite infection. Only in the past few years
they were recognized as important regulators of adaptive
immunity. The development of new methods and reagents
has enabled detection and functional analysis of these rare
cells in patients and murine disease models. Basophils are
normally present in the peripheral blood, spleen, and bone
marrow, but migrate into lymph nodes and tissues during
inflammation. They are rapidly activated by cytokines
(e.g., interleukin (IL)-3) and intact antigens that cross-link
surface-bound immunoglobulins. Activated basophils change
the phenotype of T cells toward Th2 and markedly support
humoral memory responses. Mast cells also migrate into
lymph nodes and interact with dendritic cells, T cells, and
B cells. In this review, we describe how mast cells and
basophils affect immune responses and discuss implications
for renal diseases and transplant rejection.
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Based on similarities in lineage development, activation as
well as release of mediators, basophils and mast cells (MCs)
have long been considered to be closely related to each other.
This view has been challenged by recent results in animal
models that use advanced methods to study both cell types in
vivo.1–3 Basophils and MCs derive from the granulocyte–mo-
nocyte progenitor in the bone marrow under the influence of
the transcription factors GATA-2 and CEBP/a. Cytokines like
IL-3 modulate the expansion and maturation of both cell
types.4,5 Basophils are thought to leave the bone marrow as
mature cells (characterized by expression of FceRI, CD49b
and the high affinity IL-3 receptor CD123) and are found
under basal conditions at low frequencies in the peripheral
blood, spleen, liver and bone marrow.1 During immune
responses and certain types of inflammation, basophils enter
lymph nodes and peripheral tissues.3,6 MCs complete their
maturation in peripheral tissues like the skin, intestine and
peritoneal cavity. Mature MCs (characterized by expression
of FceRI and c-Kit) are detectable in these tissues but not in
the peripheral blood, spleen, lymph nodes or bone marrow.
Although MCs are believed to have a long half-life, the half-
life of basophils is only a few days based on in vivo
measurements in mice.
IDENTIFYING BASOPHILS
Human basophils can be easily detected by flow cytometry
using surface IgE or the high affinity IL-3 receptor CD123 as
marker.7 If CD123 is used, basophils need to be distinguished
from eosinophils and plasmacytoid dendritic cells expressing
similar amounts of CD123. Activation of basophils can also
be determined by flow cytometry using upregulation of the
surface markers CD63 and CD203c, an in vitro assay
frequently used to measure reactivity of basophils to allergens
in sensitized patients.7 Basophils can be identified in humans
with antibodies directed against intracellular antigens by
immunohistochemistry.8,9 Previous efforts to identify baso-
phils by Giemsa staining or surface expression of IgE are
thought to be less specific.
Murine basophils can be clearly identified by flow
cytometry using surface staining of IgE or FceRI together
with expression of CD49b, a marker also expressed by NK
cells and other leukocytes.1 If staining with antibodies against
IgE or FceRI cannot be performed (for example, for isolation
of non-activated basophils), high expression of CD49b, low
expression of the pan leukocyte marker CD45 and absence of
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GR-1 can be used to identify basophils in the peripheral
blood and spleen.1,10 Immunohistochemical detection of
murine basophils can be achieved with antibodies against
FceRI provided that the presence of MCs is excluded.
ACTIVATION OF BASOPHILS
Activated basophils have been shown to release cytokines
(IL-4, IL-6, IL-13, TSLP), histamine, leukotrienes and the
phospholipid platelet-activating factor. A large variety of
stimuli have been described to activate or contribute to
activation of basophils in vitro. These include cross linkage of
surface Fc receptors for IgG and IgE as well as cytokines (for
example, IL-1, IL-3, IL-5, IL-18, IL-33), growth factors (for
example, GM–CSF, nerve growth factor, stem cell factor),
chemokines (for example, CCL2, CCL11, CCL24, CCL13,
CCL5, CXCL8, CXCL-1-3, CXCL-12), complement factors
(C3a, C5a), toll-like receptor 2 and others. In addition,
several molecules downregulate activation of basophils (for
example, organic cation transporter 3, leukocyte immuno-
globulin receptor 3 and FcgRIIb). For most of these factors, it
is not known which role they have in vivo. Cross-linkage of
surface immunoglobulins and IL-3 are the most important
activators of basophils, and their role in vivo has been
shown.4,5,11 Basophils express the low affinity FcgRIII, that
binds IgG containing immune complexes, and the high
affinity FceRI that binds monomeric IgE. Both immuno-
globulin receptors contain the signal-transducing Fc receptor
common g-chain (FcRg). The FcRg chain contains one
intracellular ITAM motif (immuno tyrosine activation motif)
that is phosphorylated by lyn kinase (a src family kinase
member) and recruits syk (spleen tyrosine kinase, a ZAP-70
family member) that then mediates further signal transduc-
tion. Of interest, the IL-3 receptor was recently shown to
contain the signal-transducing FcRg chain and to be
responsible for at least some of the effects of IL-3 on
basophils (for example, release of IL-4).12 FceRI receptors not
occupied by IgE are internalized and degraded unless IL-3 is
present, providing an additional link between both receptors.
The high affinity IgE receptor and antigen-specific IgE are
required for stable and prolonged binding of antigens on the
surface of basophils.1,10 Following immunization with an
antigen, only antigen-specific B cells and basophils can bind
significant amounts of intact antigen on their cell surface.
Even several months after primary immunization, sufficient
antigen-specific IgE molecules lead to antigen binding on
basophils. In contrast to stable binding of intact antigen,
activation of basophils can also occur by IgG molecules in the
absence of IgE molecules or FceRI.1 Rechallenging mice with
antigens results in an immediate release of IL-4 and IL-6 in
the spleen and bone marrow, which is almost completely
dependent on the presence of basophils. In FcRg-deficient
mice, no cytokine release was detectable after antigen
rechallenge, whereas diminished cytokine release was found
in FceRI-deficient mice.1 It has also been shown that
anaphylactic responses can be induced in mice deficient for
IgE and FceRI, but are absent in FcRg chain-deficient mice,
suggesting that IgG has an important role in anaphylaxis. Of
interest, basophils but not MCs are required for active and
passive anaphylaxis in mice.11
IL-3 is mainly produced by activated CD4þ T cells,6 but
was recently shown to be secreted by basophils after IgE-
dependent activation. IL-3 is a strong activator of basophils
that releases a wide spectrum of mediators from human and
murine basophils. IL-3 also markedly prolongs the survival of
basophils in culture by inducing anti-apoptotic pathways6
and induces basophilia in vivo by facilitating the differentia-
tion of granulocyte–monocyte progenitors to basophil line-
age-restricted progenitors.5,6 Although IL-3 is not essential
for the generation of basophils and MCs, under physiologic
conditions it is required for expansion of these cells after
infection with parasites.4
ROLE OF BASOPHILS IN IMMUNITY AND POTENTIAL ROLE IN
KIDNEY DISEASES
Apart from their role in anaphylaxis, hypersensitivity and
parasite infection, basophils have recently been shown to be
important for Th2 differentiation,3 humoral immune re-
sponses and immunological memory.1 Almost 20 years ago,
basophils were found to release IL-4 after stimulation in
murine or human bone marrow cells and splenocytes with
cross linkage of Fc-receptors or with IL-3. Only recently the
importance of basophils for production of IL-4 in models of
parasite infection or immunization has been recognized using
transgenic IL-4 reporter mice or newly developed methods to
deplete basophils in vivo. Additional factors like TSLP and
IL-6 were found to be released from basophils.1,3 Basophils
express low levels of MHC-II and can either directly present
antigens to CD4þ T cells 13 or influence the cytokine milieu
of T cells interacting with other antigen-presenting cells
(for example, dendritic cells), thus inducing a Th2 response.
The immediate activation of basophils during a memory
immune response and their importance for Th2 differentia-
tion, B-cell proliferation, plasma cell differentiation and
immunoglobulin production after rechallenge with antigens
may also have implications for the development of renal
diseases.1 A memory-type immune response predominates in
transplantation and many types of autoimmune diseases,
where alloantigens/autoantigens are continuously present.
These antigens, together with the specific antibodies, activate
basophils, which may boost ongoing humoral immune
responses and further enhance production of immunoglo-
bulins (Figure 1). Immune complexes deposited in various
structures of the kidney and autoantibodies (for example,
anti-neutrophil cytoplasmic antibody (ANCA), anti-DNA,
anti-GBM) have a prominent role in many types of kidney
diseases. In addition, donor-specific antibodies are detectable
in 5% of patients after kidney transplantation and associated
with an unfavorable outcome. In a study performed in
patients after kidney transplantation, basophils from 6 of 23
recipients showed microscopic signs of degranulation after
contact with donor lymphocytes.14 In addition, basophils
detected by Giemsa staining were present in the majority of
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renal biopsies showing acute transplant rejection and
accounted for 61% of the infiltrating granulocytes but only
1.9% of total infiltrating cells. No basophils were present in
biopsies without rejection.15
Although these studies suggest that basophils may have a
role in transplant rejection, additional investigations using
new, more reliable methods to detect basophils and measure
their activation in certain kidney diseases are needed.
Basophils should be analyzed in minimal-change disease
and focal segmental glomerulosclerosis, wherein T cells and
allergy/atopy are thought to have a major role, and Th2
skewed cytokine profiles were found in affected patients.
Basophils, as inducers of Th2 immune responses and an
important source of IL-4, could initiate the disease and have
a role in maintaining a Th2-immune response. They should
also be examined in diseases driven by immunoglobulins
directed against defined structures in the kidney (for
example, anti-GBM nephritis), deposited in the glomeruli
(for example, membranous nephropathy, lupus nephritis) or
driven by systemic vasculitis (for example, ANCA-associated
vasculitis). In these conditions, basophils may contribute to
generating and maintaining high levels of specific immuno-
globulins and thus cause disease progression. We would
propose that basophils capture antibodies (for example,
directed against neutrophils, ANCA) on their surface. After
encounters with neutrophils or fragments from neutrophils,
their specific immunoglobulins are cross linked by the
autoantigens. Subsequently, basophils become activated,
interact with T cells, and boost cellular and humoral immune
responses directed against autoantigens.
MAST CELLS—ORIGIN AND TISSUE DISTRIBUTION
In contrast to all other blood cells, which differentiate in the
bone marrow and enter the circulation as mature cells, MCs
never mature in the circulating blood. Mast cell precursors,
identified by the markers CD34þCD13þc-kitþFceRI,
migrate from the bone marrow to different tissues, where
they complete their differentiation and ultimately reside.16
Based on their granule content and therefore different
staining patterns using chloroacetate esterase staining or
toluidine blue, different subsets of MCs can be differentiated.
In rodents, we distinguished between connective tissue MCs
and mucosal MCs. Connective tissue MCs are mainly
detected in the skin and peritoneal cavity, and their granule
content consists of proteoglycan heparin, and large amounts
of histamine and carboxypeptidase A. The mucosal MCs are
found mainly in the mucosal layer of the gut and lungs; their
granules contain chondroitin sulfate and, to a much lesser
extent, histamine and carboxypeptidase A.17 In humans, two
analogous subsets can be differentiated based on their
granule content: one population only expresses the protease
tryptase, whereas the other one contains tryptase and
chymase. The latter is predominantly found within the
connective tissue, mostly located at mucosal sites.17
A dynamic spectrum of MC subsets could exist, which
adapt their phenotype and function according to the tissue
microenvironment, including inflammation and infection.
THE ROLE OF MAST CELLS AS IMMUNOMODULATORS
Although many studies show that the lack of MCs or of a
specific MC product decrease the pathology associated with
immune response,18 negative immunomodulatory functions
have been described in vivo. Importantly, the positive
immunoregulatory functions of MCs can either enhance
host defense or promote autoimmune disease. MCs are
crucial for host survival in a model of bacterial infection like
the cecal ligation and puncture model leading to peritonitis,19
or in parasitic infections.18 In experimental autoimmune
encephalomyelitis, MCs increase disease severity without
being present in the central nervous system20 as shown by the
production of IL-4 in the lymph nodes, which propagate the
development of encephalitogenic Th1 cells.21
Negative anti-inflammatory immunomodulatory func-
tions in vivo describe a central role for MC-derived IL-10.
MC-derived IL-10 markedly limits the magnitude, and
promotes the resolution of innate responses to chronic
low-dose ultraviolet B irradiation.22 MC-derived IL-10 was
shown to limit many aspects of these responses, including the
numbers of granulocytes, macrophages, and T cells at the
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Figure 1 |Roles of basophils in immune regulation. Basophils
present in the spleen and recruited to draining lymph nodes
during immune responses are activated by cytokines, for example,
IL-3 produced from CD4þ T helper cells, and by intact antigens
that cross-link surface-bound immunoglobulins (IgG and IgE).
Activated basophils express unidentified membrane-bound
molecules and release soluble factors (for example, IL-4, IL-6, TSLP)
that affect T- and B-cell function. CD4þ T cells differentiate into
Th2 cells that gain the ability for B cell help and produce IL-4, IL-5,
IL-10, IL-13, IL-21, and CD40L. Thereby basophils crucially support
B-cell proliferation, differentiation into plasma cells, and
immunoglobulin production. Immunoglobulins may be deposited
in the kidney and drive auto- and alloimmunity in the case of
autoantibodies or donor-specific antibodies. Immunoglobulins
further enhance the reactivity of basophils to antigens. Cytokines
released directly from basophils or from CD4þ T cells exposed to
basophils may also affect renal diseases (for example, by inducing
fibrosis). IgG, immunoglobin G; IL, interleukin.
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reaction sites, as well as local tissue swelling and ulceration.22
Although the mechanisms by which MC-derived IL-10 limit
tissue changes in this model remains to be fully defined, MCs
and IL-10 might influence these responses through a complex
combination of direct and indirect effector and immunor-
egulatory functions.18
Immunomodulatory functions of MCs also include direct
interaction with immune competent cells like dendritic cells
(DCs), as well as T and B cells:
Dendritic cells
MCs are often located near DCs in peripheral tissues and are
especially important in the secondary lymphoid organs. They
produce mediators like histamine, TNFa or IL-1, which
could significantly influence the migration and maturation of
DCs and exert their effects on T cells through DCs.20 Few
studies have evaluated the effect of MCs on DCs, like the
proteoglycan-induced migration of skin-derived Langerhans
DCs or a model of contact hypersensitivity, which showed
migration of DCs to the lymph nodes. This action leads to
lymph node hypertrophy, which is dependent on the presence
of MCs in the lymph nodes.23
T cells
In inflammatory conditions, MCs can migrate to secondary
lymphoid organs bringing them next to naive T cells. On the
other hand, MCs can recruit T cells to the sites of
inflammatory reaction by secretion of various cytokines,
thereby inducing adhesion molecules like ICAM-1 and
VCAM-1 on endothelial cells.18,20 Recently, a study by Lu
et al. showed an important interaction between MCs and a
subpopulation of T cells, namely the CD4þ CD25þ Foxp3þ
regulatory T cells (Treg) in a model of skin allograft rejection.
Treg-derived IL-9, an MC growth factor, was responsible for
the recruitment of MCs to the skin allograft. Owing to
blockade of IL-9, MCs were not able to migrate to the
allograft, or MCs were completely absent in MC-deficient
mice and the allograft was rejected.24
B cells
Although in vivo studies are lacking, some evidence shows the
interaction between MCs and B cells. In a model of skin
ultraviolet-irradiation, MCs primarily migrate to the B cell
areas of draining lymph nodes.23 In vitro, it has been shown
that MCs influence B-cell development and isotype class
switching through expression of cytokines such as IL-4, IL-5,
IL-6, and IL-13 and surface molecules such as CD40L.18
In addition, MCs have been shown to process and present
antigen to T cells via MHC Class I and II molecules leading to
T-cell activation.25 Regardless, the in vivo relevance of
possible antigen presentation capacity is still unclear. Of
note, MC migration from the skin to the draining lymph
nodes upon ultraviolet irradiation represents a key step in the
induction of immune suppression 23 and a critical mechan-
ism for transmitting immunoregulatory signals from the
periphery to the immune system.
THE ROLE OF MAST CELLS IN RENAL INFLAMMATION
In the autologous phase of an accelerated nephrotoxic
glomerulonephritis (GN) model, MCs protect the kidney
from inflammatory response.26 We conclude that MCs may
act as regulatory cells in the renal draining lymph nodes and
provide a shift towards a Th2-response. This has been
recently confirmed, and shown by remodeling and repair
mechanisms mediated by MCs.27 Interestingly, in a study of a
non-accelerated model of anti-GBM GN, the absence of MCs
was found to be protective.28 Our experimental anti-GBM
model is as follows (Figure 2): immature DCs are attracted to
the kidney, bind to planted antigen and then travel to the
regional renal lymph nodes. Here, DCs present the antigen to
effector T cells, which differentiate and expand, followed by
migration to the target organ, namely the kidney. We further
speculate that Treg provides cytokines like the MC growth
factor IL-9 to attract and promote the expansion of MCs,
which directly effect DCs via histamine or provide conditions
for the anti-inflammatory effect of Treg. Importantly, down-
regulation of the renal inflammatory response takes place
in the ‘headquarters’ – the regional lymph nodes, where the
‘fate of the kidney’ is decided. When translating this model
from experimental nephrology into human renal disease in
many of the immune diseases affecting the kidney, that is,
systemic lupus erythematosus, the antigen is presented
outside of the kidney and the renal lymph node is not likely
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Figure 2 |The hypothesized role of mast cells in the
pathogenesis of the autologous phase of accelerated
nephrotoxic glomerulonephritis. Immature dendritic cells (DC)
are attracted via chemokines and cytokines to the kidney, where
they take up the planted antigen. DC differentiate and migrate to
the regional draining lymph nodes and present the antigen to
effector T cells. In turn, effector T cells find their way to the
interstitium of the kidney, where they propagate renal
inflammation. Mast cells (MC), as well as regulatory T cells (Treg) in
the regional lymph nodes, have the capacity to modulate the
immune response. MC are assumed to be attracted by Treg to the
lymph nodes. Whether MC act via a direct effect on the DC or by
providing a specific milieu for the anti-inflammatory response
initiated by Treg remains to be elucidated.
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the major determinant of responses. On the other hand,
diseases like Goodpasture syndrome, wherein the antigen
is presented in the kidney, may be regulated by the
interaction of immune competent cells in renal draining
lymph nodes.
To date, few reports have investigated the possible role of
MCs in human GN. One such descriptive study showed a
significant correlation between the influx of MCs and serum
creatinine concentration (Table 1).29 MCs have gained
attention as a critical factor in the development of tissue
fibrosis in renal disorders such as chronic GN, IgA nephritis,
rapidly progressive GN and renal transplantation.28,30 Based
on observational data, MCs have been suggested to
contribute to renal deterioration in glomerular diseases by
inducing interstitial fibrosis; however, this proposal is not
supported by experimental data. Therefore, the exact role of
MCs in the progression of kidney disease and fibrosis remains
unclear, although possible scenarios have been recently
reviewed.28
Data on the role of basophils and MCs in human renal
inflammation are scarce because of the fact that improved
techniques for the detection and functional analyses have
only recently become available. Based on observational and
experimental evidence from human and animal studies,
basophils and MCs could have a prominent role in renal
inflammation. Therefore, future efforts to further examine
the role of these populations in renal diseases should be
conducted using improved techniques to detect those cells.
Furthermore, the focus of future studies should be
shifted away from the kidney towards studying secondary
lymphoid organs, where the ‘fate of the kidney’ appears to be
decided.
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